Medical pharmacy drugs that require prior authorization
For Medicare Advantage members this is referred to as Part B pharmacy drugs
Security Health Plan requires prior authorization before you receive certain home infusion and medical benefit drugs. We have partnered with Prime Therapeutics Management to manage this process to review and approve these treatments.
Medical benefit drugs may be added or removed from the list below on a quarterly basis. You can also call our Customer Service Department at (844) 293-9624 (TTY: 711) to find out which medical benefit drugs require prior authorization.
Medical benefit drug prior authorization
Security Health Plan of Wisconsin, Inc., is partnering with Prime Therapeutics Management to manage the process for reviewing and approving certain medical benefit drugs.
What are medical benefit drugs?
Medical benefit drugs are administered by a healthcare provider in the provider’s office, clinic, hospital or by home infusion. These drugs are primarily administered by:
- Intravenous (IV) injection
- IV infusion
- Intramuscular (IM) injection
- Intravitreal (ocular) injection
- Intra-articular (joints) injection
- Intrathecal injections
- Limited subcutaneous injections required in an emergency for acute conditions, or
- Drugs required as part of a surgical or diagnostic procedure
How does this benefit me?
Through the Prime Therapeutics Management program, your prescriber will have access to discuss the treatment plan and current guidelines and other clinical considerations surrounding these treatments with a physician in the same specialty from Prime Therapeutics Management. This change will help us manage your medical benefit drug costs and keep your premiums as low as possible.
Do I need to request a prior authorization or will my doctor do that for me?
Security Health Plan covers home infusion administration, including certain drugs, supplies and nursing services from an in-network provider. If your provider is in-network for your plan, the provider will obtain authorization on your behalf. If your provider is not affiliated with Security Health Plan, you are responsible for initiating and ensuring authorization is on file prior to receiving services.
To request a prior authorization for payment, have your provider contact Security Health Plan before the medical benefit drug is provided. With the exception of emergency or urgent care services, Security Health Plan will not pay for a medical benefit drug that has already been provided by a non-network healthcare provider, unless otherwise stated in your plan's Schedule of Benefits. All of the following criteria for prior authorization must be met:
- The services are not available from any network healthcare provider
- The services are a covered benefit under the member’s coverage
- The services are medically necessary and appropriate
Does this mean my prescriptions won’t be covered?
There will be no change in your member benefits. You will continue to receive the same care and access to drugs that are currently available as part of your medical and pharmacy benefits. As with all services, they must be medically necessary to be considered a covered service.
Does Medicare Part B cover home infusion drugs?
Some home infusion drugs may require prior authorization. Learn more about drugs are covered under the home infusion benefit .
How do I know if a medical benefit drug I am prescribed requires a prior authorization?
For a list of medical benefit drugs that require prior authorization, see below.
Drugs that require prior authorization
Drugs with an asterisk (*) are managed by Prime Therapeutics Management. You can contact Prime Therapeutics Management at (800) 424-8243 to initiate a prior authorization request or request a peer-to-peer review. For all other drugs contact Security Health Plan at (800) 472-2363 (TTY: 711).
Brand name |
Generic name |
Prior Authorizations submitted to: (Prime/Security Health Plan (SHP)) |
|---|---|---|
| Abraxane® | paclitaxel | * |
| Abecma® | Idecabtagene Vicleucel | * |
| Actemra® | tocilizumab | * |
| Acthar HP® | corticotropin | * |
| Adakveo® | crizanlizumab-tmca | * |
| Adbry® | tralokinumab | * |
| Adcetris® | brentuximab vedotin | * |
| Adstiladrin® | nadofaragene firadenovec-vncg | * |
| Adzynma® | adamts13, recombinant-krhn | * |
| Ahzantive® | aflibercept-mrbb | * |
| Akynzeo | fosnetupitant/palonosetron | * |
| Aldurazyme® | laronidase | * |
| Alimta® | pemetrexed | * |
| Aliquopa® | copanlisib | * |
| Aloxi® | palonosetron | * |
| Alyglo® | immune globulin intravenous, human-stwk | * |
| ALYMSYS® | BEVACIZUMAB-MALY | * |
| Amtagvi® | lifileucel | * |
| Amondys® | CASIMERSEN | * |
| AMVUTTRA® | VUTRISIRAN | * |
| Anktiva® | nogapendekin alfa inbakicept-pmln | * |
| Aphexda® | motixafortide | * |
| Aranesp® | darbepoetin | * |
| Asceniv® | immune globulin-slra | * |
| Arzerra® | ofatumumab | * |
| Asparlas® | calaspargase pegol-mknl | * |
| Aucatzyl® | obecabtagene autoleucel | * |
| Avastin® (Oncology indications only) | bevacizumab | * |
| Avsola® | infliximab-axxq | * |
| Avzivi® | bevacizumab-tnjn | * |
| Avtozma® (IV formulation) | tocilizumab-anoh | * |
| Bavencio® | avelumab | * |
| Beleodaq® | belinostat | * |
| Belrapzo | bendamustine | * |
| bendamustine | bendamustine | * |
| Bendeka® | bendamustine | * |
| Benlysta® | belimumab | * |
| Beovu® | brolucizumab-dbll | * |
| Berinert® | C1 Inhibitor | * |
| Besponsa® | inotuzumab ozogamicin | * |
| Beqvez® | fidanacogene elaparvovec-dzkt | * |
| Bivigam® | intravenous immune globulin | * |
| Bizengri® | zenocutuzumab-zbco | * |
| Bkemv® | eculizumab-aeeb | * |
| Blenrep® | BELANTAMAB MAFODOTIN-BLMF | * |
| Blincyto® | blinatumomab | * |
| Bomyntra® | denosumab-bnht | * |
| Botox® | onabotulinumtoxinA | * |
| bortezomib | bortezomib | * |
| Breyanzi® | lisocabtagene maraleucel | * |
| Brineura® | cerliponase alfa | * |
| Briumvi | ublituximab | * |
| Byooviz® | ranibizumab-nuna | * |
| cabazitaxel | cabazitaxel | * |
| CARVYKTI | ciltacabtagene autoleucel | * |
| Carimune NF® | intravenous immune globulin | * |
| Casgevy® | exagamglogene autotemcel | * |
| Cerezyme® | imiglucerase | * |
| Cimerli® | ranibizumab-eqrn | * |
| Cimzia® | certolizumab pegol | * |
| Cinqair® | reslizumab | * |
| Cinryze® | C1 Inhibitor | * |
| Columvi® | glofitamab-gxbm | * |
| Conexxence® | denosumab-bnht | * |
| Cosela® | TRILACICLIB | * |
| Cosentyx IV® | secukinumab | * |
| Crysvita | burosumab-twza | * |
| Cuvitru® | immune globulin | * |
| Cutaquig® | immune globulin | * |
| Cyramza® | ramucirumab | * |
| Danyelza® | NAXITAMAB-GQGK | * |
| Darzalex® | daratumumab | * |
| Darzalex Faspro® | daratumumab | * |
| Datroway® | datopotamab deruxtecan-dlnk | * |
| Daxxify ® | daxibotulinumtoxinA-lanm | * |
| denosumab-dssb | denosumab-dssb | * |
| denosumab-bnht (unbranded generic of Conexxence® and Bomyntra®) | denosumab-bnht (unbranded generic of Conexxence® and Bomyntra®) | * |
| Durolane® | hyaluronic acid | * |
| Dysport® | abobotulinumtoxinA | * |
| Ehertu ® | fam-trastuzumab deruxtecan-nxki | * |
| Elahere | MIRVETUXIMAB SORAVTANSINE | * |
| Elaprase® | idursulfase | * |
| Elelyso® | taliglucerase alfa | * |
| Elevidys® | delandistrogene moxeparvovec-rokl | * |
| Elfabrio® | pegunigalsidase alfa-iwxj | * |
| Elzonris | Tagraxofusp-erzs | * |
| Elrexfio ® | elranatamab-bcmm | * |
| Empliciti® | elotuzumab | * |
| Emrelis® | telisotuzumab vedotin-tllv | * |
| Encelto® | revakinagene taroretcel-lwey | * |
| Enzeevu® | aflibercept-abzv | * |
| Enspryng® | SATRALIZUMAB | * |
| Entyvio® | vedolizumab | * |
| Epkinly® | epcoritamab-bysp | * |
| Epysqli® | eculizumab-aagh | * |
| Erbitux® | cetuximab | * |
| Enjaymo™ | sutimlimab-jome | * |
| Euflexxa® | hyaluronan or derivative | * |
| Evenity® | romosozumab-aqqg | * |
| Evkeeza® | evinacumab-dgnb | * |
| Exondys 51® | eteplirsen | * |
| Eylea® | aflibercept | * |
| Eylea HD ® | aflibercept | * |
| Fabrazyme® | agalsidase beta | * |
| Fasenra | benralizumab | * |
| Feraheme | ferumoyxtol | * |
| Firazyr® | icatibant | * |
| Flebogamma® | intravenous immune globulin | * |
| Focinvez ® | fosaprepitant | * |
| Fulphila® | pegefilgrastim-jmdb | * |
| Fusilev® | levoleucovorin calcium | * |
| Fyarro® | sirolimus albumin-bound nanoparticles | * |
| FYLNETRA® | PEGFILGRASTIM-PBBK | * |
| Gamifant | emapalumab-lzsg | * |
| Gammagard® Liquid | intravenous immune globulin | * |
| Gammagard® S/D | immune globulin | * |
| Gammaked® | intravenous immune globulin | * |
| Gammaplex® | intravenous immune globulin | * |
| Gamunex-C® | intravenous immune globulin | * |
| Gazyva® | obinutuzumab | * |
| GelSyn-3® | hyaluronan or derivative | * |
| GenVisc 850 ® | hyaluronan or derivative | * |
| Givlaari® | givosiran | * |
| Haegarda | C1 Esterase Inhibitor | * |
| Halaven® | eribulin | * |
| HEMGENIX | etranacogene dezaparvovec-drlb | * |
| Herceptin® | trastuzumab | * |
| Herceptin Hylecta | trastuzumab-hyaluronidase-oysk | * |
| Hercessi® | trastuzumab-strf | * |
| Herzuma | trastuzumab | * |
| Hizentra® | subcutaneous immune globulin | * |
| Hymovis® | hyaluronan or derivative | * |
| HyQvia® | subcutaneous immune globulin | * |
| Ilumya® | Tildrakizumab-asmn | * |
| Iluvien | fluocinonide acetonide | * |
| Imaavy® | nipocalimab-aahu | * |
| Imdelltra® | tarlatamab-dlle | * |
| Imfinzi | durvalumab | * |
| Imjudo | TREMELIMUMAB-ACTL | * |
| Imuldosa® | ustekinumab-srlf | * |
| Inflectra® | infliximab-dyyb | * |
| infliximab | infliximab | * |
| Infugem® | gemcitabine hydrochloride | * |
| Injectafer | ferric carboxymaltose | * |
| Intravenous Immune globulin | intravenous immune globulin | * |
| Ixempra® | ixabepilone | * |
| Izervay ® | avacincaptad pegol | * |
| Jemperli® | DOSTARLIMAB-GXLY | * |
| Jevtana® | cabazitaxel | * |
| Jobevne® | bevacizumab-nwgd | * |
| Jubbonti® | denosumab | * |
| Kadcyla® | trastuzumab emtansine | * |
| Kalbitor® | ecallantide | * |
| Kanuma® | sebelipase alfa | * |
| Kebilidi® | eladocagene exuparvovec-tneq | * |
| Imlygic | talimogene laherparepvec | * |
| Kanjinti® | trastuzumab-anns | * |
| Keytruda® | pembrolizumab | * |
| Khapzory® | levoleucovorin | * |
| Kimmtrak | tebentafusp-tebn | * |
| Kisunla® | donanemab-azbt | * |
| Krystexxa® | pegloticase | * |
| Kyprolis® | carfilzomib | * |
| Kymriah® | tisagenlecleucel | * |
| Lamzede | velmanase alfa-tycv | * |
| lanreotide | lanreotide | * |
| Lantidra® | donislecel-jujn | * |
| Lemtrada® | alemtuzumab | * |
| Lenmeldy® | atidarsagene autotemcel | * |
| Leqvio® | inclisiran | * |
| Leqembi® | lecanemab | * |
| Libtayo | cemiplimab-rwlc | * |
| Lucentis | ranibizumab | * |
| Lumizyme | alglucosidase alfa | * |
| Lunsumio | MOSUNETUZUMAB-AXGB | * |
| Lyfgenia® | lovotibeglogene autotemcel | * |
| Lymphir® | denileukin diftitox-cxdl | * |
| Macugen | pegaptanib | * |
| Margenza TM | MARGETUXIMAB-CMKB | * |
| Marqibo® | vincristine liposomal | * |
| Mepsevii® | vestronidase alfa-vjbk | * |
| Monjuvi® | tafasitamab-cxix | * |
| Monoferric® | ferric derisomaltose | * |
| Monovisc | hyaluronic acid | * |
| Mozobil® | plerixafor | * |
| Mylotarg® | gemtuzumab ozogamicin | * |
| NEXVIAZYME® | AVALGLUCOSIDASE ALFA-NGPT | * |
| Nulibry® | FOSDENOPTERIN | * |
| Loqtorzi ® | toripalimab-tpzi | * |
| Luxturna | voretigene neparvovec-rzyl | * |
| Myobloc | rimabotulinum toxin B | * |
| Mvasi | bevacizumab-awwb | * |
| Naglazyme® | galsulfase | * |
| Neulasta® | pegfilgrastim | * |
| Neupogen® | filgrastim | * |
| Niktimvo® | axatilimab-csfr | * |
| Nivestym® | filgrastim-aafi | * |
| NPLATE® | romiplostim | * |
| Nucala® | mepolizumab | * |
| Nypozi® | filgrastim-txid | * |
| Nyvepria® | pegfilgrastim-apgf | * |
| Ocrevus® | ocrelizumab | * |
| Ocrevus Zunovo® | ocrelizumab hyaluronidase | * |
| Octagam® | intravenous immune globulin | * |
| Ogivri | trastuzumab-dkst | * |
| omalizumab-igec | omalizumab-igec | * |
| Omlyclo® | omalizumab-igec | * |
| Omvoh® | mirikizumab-mrkz | * |
| Oncaspar | pegasparagase | * |
| Onivyde® | irinotecan liposome | * |
| Onpattro® | patisiran | * |
| Ontruzant | trastuzumab-dttb | * |
| Opdivo® | nivolumab | * |
| Opdivo Qvantig | nivolumab and hyaluronidase-nvhy | * |
| Opdualag | nivolumab and relatlimab-rmbw | * |
| Opuviz® | aflibercept-yszy | * |
| Orencia® | abatacept | * |
| Orthovisc® | hyaluronan or derivative | * |
| Osenvelt® | denosumab-bmwo | * |
| Ospomyv® | denosumab-dssb | * |
| Otulfi® | ustekinumab-aauz | * |
| Oxlumo® | LUMASIRAN | * |
| Ozurdex | dexamethasone intravitreal implant | * |
| paclitaxel | paclitaxel | * |
| PadcevTM | enfortumab vedotin-ejfv | * |
| palonosetron hydrochloride (avyxa) | palonosetron hydrochloride (avyxa) | * |
| Panzyga | intravenous immune globulin | * |
| Pavblu® | aflibercept-ayyh | * |
| Pedmark | sodium thiosulfate | * |
| pemetrexed | pemetrexed | * |
| Pemfexy® | pemetrexed | * |
| Pemrydi rtu ® | pemetrexed | * |
| Penpulimab-kcqx | Penpulimab-kcqx | * |
| Pepaxto® | MELPHALAN FLUFENAMIDE | * |
| Perjeta® | pertuzumab | * |
| Phesgo® | pertuzumab, trastuzumab, and hyaluronidase | * |
| Piasky® | crovalimab-akkz | * |
| Polivy® | polatuzumab vedotin-piiq | * |
| Pombiliti® | cipaglucosidase alfa-atga | * |
| Portrazza® | necitumumab | * |
| Privigen® | intravenous immune globulin | * |
| Procrit®/Epogen® | epoetin alfa | * |
| Proleukin® | aldesleukin | * |
| Prolia | denosumab | * |
| Provenge® | sipuleucel-t | * |
| Pteligeo® | mogamulizumab-kpkc | * |
| Purified Cortrophin Gel® | repository corticotropin injection USP | * |
| Pyzchiva® | ustekinumab-ttwe | * |
| Qalsody® | tofersen | * |
| Radicava® | edaravone | * |
| Reblozyl® | luspatercept-aamt | * |
| RELEUKO | FILGRASTIM-AYOW | * |
| Remicade® | infliximab | * |
| Renflexis® | infliximab-abda | * |
| Retacrit® | epoetin alfa-epbx | * |
| Retisert | fluocinonide acetonide intravitreal | * |
| Revcovi® | elapegademase-lvlr | * |
| Riabni TM | RITUXIMAB-ARRX | * |
| Rituxan® | rituximab | * |
| Rituxan® | rituximab hyclea | * |
| Rivfloza® | nedosiran | * |
| Roctavian® | valoctocogene roxaparvovec-rvox | * |
| ROLVEDON | EFLAPEGRASTIM-XNST | * |
| Ruconest® | C1 Esterase Inhibitor [recombinant] | * |
| Ruxience® | rituximab-pvvr | * |
| RYBREVANT® | AMIVANTAMAB-VMJW | * |
| Rylaze® | asparaginase Erwinia chrysanthemi (recombinant)-rywn | * |
| Ryoncil® | remestemcel-L-rknd | * |
| Ryplazim ® | plasminogen, human-tvmh | * |
| Rystiggo® | rozanolixizumab-noli | * |
| Rytelo® | imetelstat | * |
| Ryzneuta® | efbemalenograstim alfa-vuxw | * |
| Sandostatin® LAR | octreotide | * |
| SAPHNELO® | ANIFROLUMAB-FNIA | * |
| Sarclisa® | isatuximab-irfc | * |
| Scenesse® | afamelanotide | * |
| Selarsdi® | ustekinumab-aekn | * |
| Signifor LAR® | pasireotide | * |
| Simponi ARIA® | golimumab | * |
| Skysona | elivaldogene autotemcel | * |
| Skyrizi® IV | risankizumab-rzaa | * |
| Soliris® | eculizumab | * |
| Somatuline Depot® | lanreotide | * |
| Spevigo® | spesolimab | * |
| Spinraza® | nusinersen | * |
| Stelara®- IV | ustekinumab | * |
| Steqeyma® | ustekinumab-stba | * |
| Stimufend® | pegfilgrastim-fpgk | * |
| Stoboclo® | denosumab-bmwo | * |
| Supartz® | hyaluronan or derivative | * |
| Sustol® | granisetron extended release | * |
| Susvimo® | ranibizumab | * |
| Syfovre | pegcetacoplan | * |
| Sylvant® | siltuximab | * |
| Synagis® | pavilzumab | * |
| Synojoynt® | sodium hyaluronate | * |
| Synvisc® | hyaluronan or derivative | * |
| Synvisc-One® | hyaluronan or derivative | * |
| Takhzyro | lanadelumab-flyo | * |
| Talvey ® | talquetamab-tgvs | * |
| Tecelra® | afamitresgene autoleucel | * |
| Tecvayli | TECLISTAMAB-CQYV | * |
| Tecartus® | brexucabtagene autoleucel | * |
| Tecentriq® | atezolizumab | * |
| Tepezza® | teprotumumab-trbw | * |
| Tevimbra® | tislelizumab | * |
| Tezspire® | tezepelumab-ekko | * |
| Tivdak® | tisotumab vedotin-tftv | * |
| tocilizumab-anoh (IV formulation) | tocilizumab-anoh | * |
| Tofidence® | tocilizumab-bavi | * |
| Trazimera® | trastuzumab-qyyp | * |
| Treanda® | bendamustine | * |
| TriVisc® | sodium hyaluronate | * |
| IV Tremfya® | guselkumab | * |
| Trodelvy® | sacituzumab govitecan-hziy | * |
| Truxima | rituximab-abbs | * |
| Tyenne® | tocilizumab-aazg | * |
| Tysabri® | natalizumab | * |
| Tyruko ® | natalizumab-sztn | * |
| Tzield | teplizumab-mzwv | * |
| Udenyca | pegfilgrastim-cbqv | * |
| Ultomiris | ravulizumab-cwvz | * |
| Unloxcyt® | cosibelimab-ipdl | * |
| Uplizna® | inebilizumab-cdon | * |
| Vabysmo™ | faricimab-svoa | * |
| Vectibix ® | panitumumab | * |
| VEGZELMA | BEVACIZUMAB-ADCD | * |
| Velcade® | bortezomib | * |
| Veopoz ® | pozelimab-bbfg | * |
| Vidaza | azacitidine | * |
| Viltepso® | viltolarsen | * |
| Vimizim® | elosulfase alfa | * |
| Vivimusta® | bendamustine hydrochloride injection | * |
| Visco-3® | hyaluronate sodium | * |
| Vpriv® | velaglucerase alfa | * |
| Vyepti® | eptinezumab-jjmr | * |
| Vyloy® | zolbetuximab-clzb | * |
| Vyjuvek® | beremagene geperpavec | * |
| Vyondys-53® | golodirsen | * |
| Vyvgart® | efgartigimod Alfa-fcab | * |
| Vyvgart Hytrulo® | efgartigimod alfa and hyaluronidase | * |
| Vyxeos® | daunorubicin and cytarabine, liposome | * |
| Wezlana® | ustekinumab-auub | * |
| Winrevair® | sotatercept-csrk | * |
| Wyost® | denosumab-bbdz | * |
| Xembify® | immune globulin | * |
| Xenpozyme® | olipudase alfa | * |
| Xbryk® | denosumab-dssb | * |
| Xgeva® | denosumab | * |
| Xipere® | triamcinolone acetonide | * |
| Xolair® | omalizumab | * |
| Yervoy® | ipilimumab | * |
| Yesintek® | ustekinumab-kfce | * |
| Yondelis® | trabectedin | * |
| Yutiq | fluocinolone | * |
| Zaltrap® | aflibercept | * |
| ZepzelcaTM | lurbinectedin | * |
| Zevaskyn® | prademagene zamikeracel | * |
| Ziihera® | zanidatamab-hrii | * |
| Zolgensma | Onasemnogene Abeparvovec-xioi | * |
| Ziextenzo® | pegfilgrastim | * |
| Zilretta | triamcinolone | * |
| Zirabev | bevacizumab-bvzr | * |
| Zynlonta® | LONCASTUXIMAB TESIRINE-LPYL | * |
| Zynteglo® | betibeglogene autotemcel | * |
| Zynyz | retifanlimab-dlwr | * |
| Yescarta® | axicabtagene ciloleucel) | * |
| Yesafili® | aflibercept-jbvf | * |
| Yimmugo® | immune globulin intravenous, human | * |
